focus -WSS

focus

author：fashion 2025-09-30 17:59:44 - browse：5425

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： How AI helped researchers track recovery from depression

focus

WSS

Experts study whether long Covid risk adds up with each reinfection

Lasker Awards 2023: Winners in biomedical research

Senate HELP committee spars over health care workforce policies

Drug for rare kidney disease narrowly misses mark in clinical trial

Changes to biosimilar regulatory framework must prioritize patients

Food as medicine: Medically tailored meals may get standardized

entertainment

focus

knowledge

Psychedelics group wrestles with new pharma identity

Primary care physicians play key roles in Alzheimer's management

Medicare details structure of new drug price negotiation program

Why the world’s most expensive drug might be worth the price

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Microbiome research is starting to find links to chronic diseases

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: Merck, Vertex, and Viking updates

United colonoscopy coverage change 'may cost lives,' doctors say

Eliminate the waiting period for sterilization covered by Medicaid

knowledge

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Ukraine and a new approach to mental health in war

Biotech stock slump in 2023: awaiting the turnaround

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Microbiome research is starting to find links to chronic diseases

Oprah kicked off a national conversation on obesity. Let's have it

hotspot

focus

explore

hotspot